(19)
(11) EP 2 190 417 A2

(12)

(88) Date of publication A3:
28.01.2010

(43) Date of publication:
02.06.2010 Bulletin 2010/22

(21) Application number: 09725377.7

(22) Date of filing: 26.03.2009
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61K 31/00(2006.01)
A61K 31/64(2006.01)
 A61K 9/50(2006.01)
A61K 31/4439(2006.01)
(86) International application number:
PCT/US2009/038365
(87) International publication number:
WO 2009/120844 (01.10.2009 Gazette 2009/40)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 26.03.2008 US 39691 P

(71) Applicant: Teva Pharmaceutical Industries Ltd.
49131 Petah Tiqva (IL)

(72) Inventors:
  • KANARI, Itamar
    44235 Kefar Sava (IL)
  • LIEBOVICI, Minutza
    42312 Netanya (IL)
  • FOX, Michael
    67291 Tel Aviv (IL)

(74) Representative: Lumsden, Stuart Edward Henry 
D Young & Co LLP 120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)

   


(54) PHARMACEUTICAL COMPOSITIONS COMPRISING INSULIN SENSITIZER AND INSULIN SECRETAGOGUE